Photo of man with woman standing behind him, embracing him with her arms around his shoulders Photo of man with woman standing behind him, embracing him with her arms around his shoulders

Actor portrayals.

Actor portrayals.

Actor portrayals.

For people living with blood cancers,

Discover what’s possible with TREGZI . . .

. . . the first and only precision-engineered stem cell and T cell therapy for allogeneic transplant.

TREGZI is a unique type of stem cell and T cell therapy for allogeneic transplant that is different than traditional allogeneic stem cell transplant approaches. It’s been shown to improve survival without chronic graft-versus-host disease (also called cGVHD) in adults with blood cancers.

It’s an important part of the treatment journey

Hearing that you or someone you care for needs an allogeneic stem cell transplant can be overwhelming. Yet, because allogeneic stem cell transplant offers the chance for a cure, it can be an important part of the treatment journey—a clear next step. To help reduce complications, find a donor, and improve outcomes, planning for transplant starts early, sometimes right after receiving the diagnosis.

The benefits of allogeneic stem cell transplant are well known

Allogeneic stem cell transplant offers a chance for a cure for blood cancers.

Transplant procedures can be hard on the body. There is a chance for serious side effects, including infections and graft-versus-host disease (GVHD), which can impact outcomes and quality of life.

TREGZI offers a more precise approach

TREGZI is a precision-engineered stem cell and T cell therapy for allogeneic transplant that can deliver the intended benefits of a transplant while lowering the risks of some of the complications that can occur with traditional allogeneic stem cell transplant approaches.

icon of arrows pointing up, right, and left

What makes
TREGZI unique

Learn more about TREGZI, including what it is and how it differs from traditional allogeneic stem cell transplant.

See What’s Different

Q&A comment bubbles icon

Get answers to
common questions

Get answers to frequently asked questions about TREGZI, the treatment experience, financial support, and more.

Learn More

Actor portrayals.

IMPORTANT SAFETY INFORMATION AND INDICATION

ISI tray

ISI tray

INDICATION

  • TREGZI is a treatment used in stem cell transplant for adult patients who have blood cancer to rebuild the blood and immune systems and improve survival without chronic graft-versus-host disease (cGVHD).
  • TREGZI is made by selecting certain types of blood cells from a matched donor.

IMPORTANT SAFETY INFORMATION

Before you receive TREGZI, tell your healthcare provider about all your medical conditions, including if you have:

  • Lung or breathing problems
  • Heart problems
  • Liver problems
  • Kidney problems
  • A recent or active infection

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

TREGZI can cause serious side effects, including:

  • Graft Failure. Failure to rebuild the blood and/or immune system, which may be fatal, can occur after receiving TREGZI. Your healthcare provider will monitor you closely after TREGZI administration.

  • Graft-Versus-Host Disease (GVHD). Immune reactions from the donor’s cells may occur soon (days) or long (months) after receiving TREGZI. Tell your healthcare provider right away about any signs and symptoms including rash, joint pain, diarrhea, or yellowing of the eyes.
  • Infusion Reactions. Infusion reactions can occur after TREGZI infusion. Tell your healthcare provider right away about any signs and symptoms including fever, chills, flushing, fatigue, shortness of breath, and dizziness/lightheadedness.
  • Secondary Cancer and Cancer from Donor Cells. New cancers can develop after treatment with TREGZI. If you are diagnosed with a new cancer after treatment, contact Orca Bio at 1-877-290-6722.
  • Transfer of Serious Infections. Transfer of serious infectious diseases can occur because TREGZI is made from the human blood cells of a donor. Transfer may occur even though donors are screened and tested for infectious diseases.

The most common side effects of TREGZI include inflammation of the digestive tract, diarrhea, rash, viral infections, infections from an unknown pathogen, abdominal pain, vomiting, nausea, bacterial infections, bleeding, acute graft-versus-host disease (aGVHD), swelling and fungal infections.

These are not all the possible side effects of TREGZI. Tell your healthcare provider if you have any side effect that bothers you or that does not go away. Call your doctor for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

INDICATION

  • TREGZI is a treatment used in stem cell transplant for adult patients who have blood cancer to rebuild the blood and immune systems and improve survival without chronic graft-versus-host disease (cGVHD).
  • TREGZI is made by selecting certain types of blood cells from a matched donor.

Please see accompanying full Prescribing Information including Patient Information.